Unraveling the rapid progression of non-target lesions: risk factors and the therapeutic potential of PCSK9 inhibitors in post-PCI patients
Authors
- Zhenzhu Liu (ORCID: https://orcid.org/0000-0003-1982-0220)
- Lili Yin
- Xiaodan Fu (ORCID: https://orcid.org/0000-0001-6969-7369)
- Jinglin Zhao (ORCID: https://orcid.org/0000-0003-4687-3846)
- Jiajie Mei (ORCID: https://orcid.org/0000-0003-4933-8216)
- Yuxing Wang (ORCID: https://orcid.org/0000-0002-2028-603X)
- Zhaohong Geng (ORCID: https://orcid.org/0000-0003-4915-4193)
- Xiaodong Zhang (ORCID: https://orcid.org/0000-0001-5039-6363)
- Lijiao Zhang
- Wenli Xie (ORCID: https://orcid.org/0000-0002-8970-4172)
- Ming Yu (ORCID: https://orcid.org/0009-0004-4240-0931)
- Peng Qu (ORCID: https://orcid.org/0009-0003-6108-8384)
Institutions
- Dalian Medical University (CN)
- Second Affiliated Hospital of Dalian Medical University (CN)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2024-09-18
- DOI
- https://doi.org/10.1186/s12872-024-04186-2
- Citations
- 3
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 1.72